Marrone Bio Innov (MBII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,053 | 21,694 | 37,180 | 24,455 | 19,145 |
| Marketable Securities | N/A | N/A | N/A | 13,677 | N/A |
| Receivables | 3,592 | 2,347 | 1,787 | 4,687 | 2,970 |
| Inventories | 8,482 | 9,064 | 12,644 | 12,717 | 4,872 |
| Other current assets | 2,688 | 1,596 | 1,797 | 2,861 | 0 |
| TOTAL | $26,875 | $35,912 | $54,723 | $59,751 | $27,465 |
| Non-Current Assets | |||||
| PPE Net | 17,343 | 18,445 | 20,166 | 9,361 | 3,528 |
| Other Non-Current Assets | 1,765 | 16,844 | 2,293 | 806 | 2,785 |
| TOTAL | $19,108 | $35,289 | $22,459 | $10,167 | $6,313 |
| Total Assets | $45,983 | $71,201 | $77,182 | $69,918 | $33,778 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 252 | 244 | 12,636 | 157 | 8,572 |
| Accounts payable and accrued liabilities | 1,385 | 2,007 | 5,841 | 4,460 | 2,104 |
| Accrued Expenses | 7,126 | 6,864 | 6,321 | 4,534 | 3,023 |
| Other current liabilities | N/A | N/A | 1,044 | N/A | 2,185 |
| TOTAL | $15,249 | $12,849 | $31,202 | $15,530 | $38,933 |
| Non-Current Liabilities | |||||
| Long Term Debt | 57,750 | 57,021 | 9,667 | 12,280 | 27,108 |
| Deferred Revenues | 5,647 | 3,087 | 3,521 | 4,978 | 324 |
| Other Non-Current Liabilities | 1,381 | 1,314 | 847 | 571 | 481 |
| TOTAL | $60,918 | $60,374 | $12,749 | $15,357 | $29,480 |
| Total Liabilities | $76,167 | $73,223 | $43,951 | $30,887 | $68,413 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 24,767 | 24,584 | 24,465 | 19,616 | N/A |
| Retained earnings | -234,647 | -203,576 | -159,848 | -108,189 | -75,569 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 39,612 |
| TOTAL | $-30,184 | $-2,022 | $33,231 | $39,031 | $-34,635 |
| Total Liabilities And Equity | $45,983 | $71,201 | $77,182 | $69,918 | $33,778 |